CT HB06810

Covered entities participating in the federal 340B Drug Pricing Program would be required to file periodic reports detailing how they use savings from discounted prescription drugs to benefit patients

Compliance with the reporting requirement would become a condition of eligibility for Medicaid reimbursement in Connecticut

Health care entities that fail to report on their use of 340B savings would have Medicaid funding withheld

The bill amends Connecticut general statutes to create new transparency obligations for 340B program participants